Riyadh biotech summit to gather global leaders in September 2026

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together scientists, investors, policymakers and health innovators. The event is tied to Saudi Arabia’s National Biotechnology Strategy and aims to advance the Kingdom’s biotech ecosystem, investment pipeline and workforce development.

Why it matters: - The summit is designed to position Saudi Arabia as a regional and global hub for biotech innovation, investment and talent. - The event supports the National Biotechnology Strategy, which targets $34.6 billion in non-oil GDP from biotechnology by 2040. - The program links research, regulation, manufacturing and commercialization, which matters because progress in one stage depends on capabilities across the full biotech value chain.

What happened: - Riyadh Global Medical Biotechnology Summit 2026 will take place Sept. 14-16 in Riyadh, Saudi Arabia. - The fourth edition is expected to bring together scientists, investors, policymakers and health innovators. - More than 15,000 visitors are expected to attend. - The summit is expected to feature more than 100 local and international speakers. - Organizers expect 200 biotechnology and health brands to participate. - More than 80 public- and private-sector entities are expected to take part. - Delegations from more than 70 countries are expected. - Organizers are targeting more than 65 deals and memorandums of understanding over the three-day event.

The details: - The scientific program covers six main themes: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. - The agenda spans population-scale genomics, AI-enabled drug discovery, local biomanufacturing, regulatory science, commercialization and investment. - The summit is organized under the supervision of the Ministry of National Guard, represented by Health Affairs. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Ministry of Investment, Invest Saudi and the Saudi Data and AI Authority are the main strategic partners. - Registration is open for delegates, participating companies and industry partners. - More information is available in the official summit details. - The summit uses the theme “Building the Foundations of Excellence in Biotechnology.” - Prof. Bandar Alknawy said this year’s focus shifts from global reach to structural depth. - Alknawy said the summit is highlighting global partnerships with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug discovery. - Alknawy said durable biotech growth depends on advanced labs, integrated research centers, clinical trial networks, biomanufacturing capacity and digital platforms. - Alknawy said investment in national talent is also essential to build a resilient biotech ecosystem.

Between the lines: - Saudi Arabia is framing biotech as a strategic economic sector, not just a research field. - The mix of government, academic, investor and industry participants suggests the summit is meant to accelerate deals and turn research into commercial activity. - The emphasis on regulation, manufacturing and translational science signals an effort to build the infrastructure needed for long-term biotech scaling.

What's next: - Delegates, companies and sector partners can continue registering ahead of the September event. - The summit will publish its detailed scientific program and speaker list through the event website. - The three-day meeting is expected to produce partnerships, agreements and policy-focused discussions tied to the National Biotechnology Strategy.

The bottom line: - Riyadh is using its flagship biotech summit to showcase progress and draw global partners into a larger push to build a full-scale biotechnology ecosystem.